glp-1 fda approved indications Live Updates on Semaglutide's Current and Future Uses GLP-1-based therapies for diabetes, obesity

This trend appears to be continuing, bringing net costs even lower than presented in this report (based on data into 2024)

Semaglutide, also known by other brand names, is still making waves on the Internet even after years of FDA approval

For example, a large-scale retrospective study using data from the US Department of Veterans Affairs showed GLP-1 use to be associated with a reduced risk of 42 conditions in a diabetic population1

PlexusDx offers compounded semaglutide starting at $149/month to help you explore cardiovascular benefits with medical guidance

These convenient powder drink mixes create refreshing daily drinks that support digestion, energy, and metabolism as part of a consistent daily health routine

PlexusDx explores the mechanism behind this surprising benefit